Medimi AB (publ)

NGM:MEDIMI Stock Report

Market Cap: SEK 6.5m

Medimi Valuation

Is MEDIMI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MEDIMI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MEDIMI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MEDIMI's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MEDIMI?

Key metric: As MEDIMI is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MEDIMI. This is calculated by dividing MEDIMI's market cap by their current revenue.
What is MEDIMI's PS Ratio?
PS Ratio1.6x
SalesSEK 4.17m
Market CapSEK 6.47m

Price to Sales Ratio vs Peers

How does MEDIMI's PS Ratio compare to its peers?

The above table shows the PS ratio for MEDIMI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.6x
MONI Monivent
4.3xn/aSEK 10.1m
VSD B Vibrosense Dynamics
4.7xn/aSEK 12.0m
EVOL Evolear
0.9xn/aSEK 2.2m
TENDO Tendo
0.6xn/aSEK 2.2m
MEDIMI Medimi
1.6xn/aSEK 6.5m

Price-To-Sales vs Peers: MEDIMI is good value based on its Price-To-Sales Ratio (1.6x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does MEDIMI's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
ARJO B Arjo
0.8x3.6%US$808.67m
CARE Careium
0.8x10.2%US$62.46m
BOUL Boule Diagnostics
0.5x5.6%US$23.73m
ARCOMA Arcoma
0.8x8.3%US$13.05m
MEDIMI 1.6xIndustry Avg. 4.7xNo. of Companies12PS048121620+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MEDIMI is good value based on its Price-To-Sales Ratio (1.6x) compared to the Swedish Medical Equipment industry average (4.7x).

Price to Sales Ratio vs Fair Ratio

What is MEDIMI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MEDIMI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MEDIMI's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Iconovo

SEK 79.9m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.02

7D

-1.6%

1Y

-46.3%

Arcoma

SEK 144.4m

Develops, produces, and provides radiology solutions worldwide.

ARCOMA

SEK 10.95

7D

1.4%

1Y

47.0%

Dignitana

SEK 96.7m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.20

7D

4.3%

1Y

-45.5%